YKL-46 as a marker of joint involvement in inflammatory bowel disease

被引：33

作者：

Bernardi, D

Podswiadek, M

Zaninotio, M

Punzi, L

Plebani, M

机构：

[1] Azienda Osped Padova, Dept Lab Med, I-35128 Padua, Italy

[2] Univ Hosp Padua, Dept Lab Med, I-35128 Padua, Italy

[3] Univ Padua, Div Rheumatol, I-35128 Padua, Italy

来源：

CLINICAL CHEMISTRY | 2003年 / 49卷 / 10期

关键词：

D O I：

10.1373/49.10.1685

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 [基础医学];

摘要：

[No abstract available]

引用

页码：1685 / 1688

页数：4

共 30 条

[1]

BEST WR, 1979, GASTROENTEROLOGY, V77, P843

[2]

Serum YKL-40 and colorectal cancer [J].

Cintin, C ;

Johansen, JS ;

Christensen, IJ ;

Price, PA ;

Sorensen, S ;

Nielsen, HJ .

BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1494-1499

[3]

d'Erill GM, 2001, CLIN CHEM, V47, P1498

[4]

YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes [J].

De Ceuninck, F ;

Gaufillier, S ;

Bonnaud, A ;

Sabatini, M ;

Lesur, C ;

Pastoureau, P .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 285 (04) :926-931

[5]

FRASER CG, 1989, CRIT REV CL LAB SCI, V27, P409

[6]

Garnero P, 2000, ARTHRITIS RHEUM-US, V43, P953, DOI 10.1002/1529-0131(200005)43:5<953::AID-ANR1>3.0.CO

[7]

2-Q

[8]

HARRIS EK, 1974, CLIN CHEM, V20, P1535

[9]

Harvey S, 1998, CLIN CHEM, V44, P509

[10]

Stability of YKL-40 concentration in blood samples [J].

Hogdall, EVS ;

Johansen, JS ;

Kjaer, SK ;

Price, PA ;

Blaakjaer, J ;

Hogdall, CK .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2000, 60 (04) :247-251

← 1 2 3 →